A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
about
Radiation Therapy after Radical Prostatectomy: Implications for CliniciansGaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeLong-term oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer: Systemic review and meta-analysis of 5-year and 10-year follow-up dataAdjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.Counseling patients about sexual health when considering post-prostatectomy radiation treatment.Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis.Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapyGenomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced diseaseSalvage radiotherapy after radical prostatectomy.Salvage versus adjuvant radiotherapy after radical prostatectomy: argument for adjuvant radiotherapyPhysician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.Is there an optimal management for localized prostate cancer?Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling.Postprostatectomy radiation therapy: an evidence-based review.Radiotherapy in the management of prostate cancer after radical prostatectomy.Long-term complications in men who have early or late radiotherapy after radical prostatectomy.Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.Opportunity lost and found: Any easy way to improve outcomes for prostate cancer patients in the postoperative setting?Radiotherapy after radical prostatectomy: immediate or early delayed?Prostate cancer: Benefit and safety of adjuvant radiation therapy.Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?Radical prostatectomy for cT3-4 disease: an evaluation of the pathological outcomes and patterns of care for adjuvant radiation in a national cohort.Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.Post-prostatectomy radiation therapy for locally recurrent prostate cancer.Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy : Long-term follow-up of a single-center survey.CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed.Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.
P2860
Q26744531-9E61E809-B27C-4918-8802-D9DA769800DEQ26751574-F06563AF-0A9B-4CC1-AB35-040FB1A82D4AQ26777094-61C86AE8-BD49-45A8-9FE7-C751E62B636FQ28541950-C1A24CCE-9A61-48F4-A4AC-7913565BE777Q33710312-F398AAF7-BE89-42B7-BB5D-EEFD8B55CAC7Q34725046-068298B6-270F-4959-ACA8-FF44B71B6C59Q35167186-FBFDAEE2-C20F-4B7E-9AFE-20A09B6F729EQ35902806-2FA8A3C9-5E26-4192-B5A1-5EB3DEDBA849Q35924258-E4D5C63C-1586-4445-B7B5-24344F965FDEQ36945088-060AB2B3-DFE3-4DD6-9E0E-A73913B54CF1Q36990694-C2A0C5B7-C90E-4D27-8416-B65517C4DB7FQ37216103-A3EADDFE-E08F-4619-80CD-F73E613E3890Q37216107-DD918AA8-7D49-453D-BF6C-F7B989ABDDA1Q37427663-6DB8BA9A-EF9D-4C2D-B091-F86333ED1421Q37780107-27B44799-0099-438D-9037-56062A4F8180Q37889109-4E2EAEF9-439C-472B-BE24-4C93EDCA951BQ37938241-357663F9-0CEB-4458-B68A-F18DCF7B78B1Q37960204-0D612C5D-4FB3-45B9-AEA0-67FBD4E518A7Q38104412-A95DB6F7-D873-42AE-8303-6B4FDE01F098Q38248286-73F58C35-A2B7-4053-B9CD-38DAAD4FF810Q38264782-D4DAE497-2B5E-4166-A357-467D9CE33956Q38877792-457EA213-C5FE-4338-AC1F-0589396FDC8DQ39356227-1C996B66-44EE-4684-ADAF-B6E61CC3FA6BQ41984611-4DA00F39-026D-4C7A-BDC3-65B55D9CE0ACQ44905750-00AA2836-195E-454F-B0ED-0529624026CAQ45934623-9760A600-8FF4-4860-82A9-991F8CA392F6Q46062252-CD54868F-9ABB-4BB1-8BD1-259AD4C683EAQ46509230-C41E9935-709D-48BF-B27A-82627E5A3FD7Q47645461-A3D676CC-53C7-4B52-A9B5-749D1F78A266Q47966425-AF992445-8057-4DCB-9398-CFCD738EB896Q51751196-B514F677-A79F-434A-845D-5B5BAC8BDD33Q53471606-63950E4F-908C-4871-9042-23D59BA6553CQ55456247-8D230DF4-27D6-444F-9E12-2BEC21CE6398
P2860
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@en
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@nl
type
label
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@en
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@nl
prefLabel
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@en
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@nl
P2093
P2860
P50
P1433
P1476
A multi-institutional matched- ...... y for pT3-4N0 prostate cancer.
@en
P2093
Alan Pollack
Alexandra L Hanlon
Andrew J Stephenson
Charles N Catton
Claus G Roehrborn
Daniel W Lin
Deborah A Kuban
Howard M Sandler
Jeff M Michalski
Jeffrey D Forman
P2860
P304
1298-302; discussion 1302-4
P356
10.1016/J.UROLOGY.2008.05.057
P407
P577
2008-07-30T00:00:00Z